Challenging cases in mantle cell lymphoma
23 February 2021 - 50 Minutes

Challenging cases in mantle cell lymphoma

On behalf of the Scientific Committee you are invited to join us for this LIVE interactive broadcast.

Professor Georg Hess and Dr Ana Marin Niebla will discuss challenging cases in mantle cell lymphoma with particular focus on:

•    Risk stratification
•    1st line therapy selection
•    Salvage treatment options
•    Role of transplantation

During the live broadcast you will have the ...

more info...

EM-49344
ON DEMAND webinar: A new chapter in the treatment of patients with relapsed/refractory multiple myeloma
17 February 2021 - 47 Minutes

ON DEMAND webinar: A new chapter in the treatment of patients with relapsed/refractory multiple myeloma

Video recording by the congress organisers of the Janssen Symposium from the EHA-EBMT 3rd European CAR T-Cell Meeting that took place on 4 February 2021.

Learning objective:

After participating in this webinar, viewers should be able to:

  • Discuss recent data updates relating to the use of cellular therapies in the management of patients with multiple myeloma
  • Evaluate how ...

more info...

EM-53596
What's new in the ESMO guidelines?
11 February 2021 - 48 Minutes

What's new in the ESMO guidelines?

Learning objective:

After participating in this broadcast you should be able to:

  • Explain the latest updates to the ESMO guidelines for managing patients with multiple myeloma  

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Philippe Moreau (France)
more info...

EM-48507
Managing hematological malignancies in the COVID-19 era: 12 months on, what have we learned?
9 February 2021 - 49 Minutes

Managing hematological malignancies in the COVID-19 era: 12 months on, what have we learned?

Join our expert faculty for this series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL).

Pre-register for your chance to submit questions to our expert faculty in advance of each broadcast. During each live broadcast you will also be able ...

more info...

EM-49343
B-cell malignancies in the spotlight: Interpreting data from ASH 2020
27 January 2021 - 63 Minutes

B-cell malignancies in the spotlight: Interpreting data from ASH 2020

Learning objective:

After participating in this webinar, viewers should be able to:

  • Key updates from ASH 2020 on the treatment of mantle cell lymphoma
  • What’s new in Waldenstrom’s macroglobulinemia?
  • Updates on B-cell lymphomas: the best of the rest from ASH 2020

 

Faculty:

  • Christian Buske (Germany)
  • Georg Hess (Germany)
  • Steve Le Gouill (France)
  • Steven Treon (USA)

 

more info...

EM-49331
Will ASH 2020 change how we manage CLL?
26 January 2021 - 62 Minutes

Will ASH 2020 change how we manage CLL?

Learning objective:

After participating in this webinar, viewers should be able to:

  • Which frontline treatment for your CLL patients?
  • What does ASH 2020 promise for the future of CLL?

 

Faculty:

  • Ulrich Jäger (Austria)
  • John Gribben (UK)
  • Paolo Ghia (Italy)
  • Peter Hillmen (UK)

 

more info...

EM-49329
The evolution of treatment options for patients with relapsed/refractory multiple myeloma
21 January 2021 - 63 Minutes

The evolution of treatment options for patients with relapsed/refractory multiple myeloma

Learning objective:

After participating in this webinar, viewers should be able to:

  • Updates from ASH 2020 on the management of patients with relapsed / refractory MM 

 

Faculty:

  • Michel Delforge (Belgium)
  • Maria-Victoria Mateos (Spain)

 

more info...

EM-49327
Key considerations when managing patients with newly diagnosed multiple myeloma and amyloidosis
20 January 2021 - 46 Minutes

Key considerations when managing patients with newly diagnosed multiple myeloma and amyloidosis

Learning objective:

After participating in this webinar, viewers should be able to:

  • Evaluating the data from ASH 2020 on the management of patients with newly diagnosed MM 

 

Faculty:

  • Michel Delforge (Belgium)
  • Maria-Victoria Mateos (Spain)

 

more info...

EM-49326
Perspectives on current treatment modalities for older patients with acute myeloid leukemia (AML)
12 January 2021 - 47 Minutes

Perspectives on current treatment modalities for older patients with acute myeloid leukemia (AML)

and those who are unfit for intensive chemotherapy: insights after ASH 2020

Learning objective:

After participating in this webinar, viewers should be able to:

  • Discuss the data from ASH2020 relating to the current management of older or unfit patients with acute myeloid leukemia

 

Moderator: Charles Craddock (United Kingdom)

 

Faculty:

  • Uwe Platzbecker (Germany)
  • Agnieszka Wierzbowska (Poland)

 

more info...

EM-48614
ASH 2020 data on management of relapsed/refractory MM: what's for my practice?
11 January 2021 - 49 Minutes

ASH 2020 data on management of relapsed/refractory MM: what's for my practice?

Learning objective:

After participating in this broadcast you should be able to:

  • Evaluate how data from ASH 2020 relating to the management of patients with relapsed/refractory MM could impact on daily clinical practice

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Philippe Moreau (France)
more info...

EM-45078